Dr. Mahdi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
417 Quarry Lakes Dr
Sandusky, OH 44870Phone+1 216-444-2200Fax+1 216-444-9423- Is this information wrong?
Education & Training
- Cleveland Clinic FoundationFellowship, Gynecologic Oncology, 2012 - 2015
- University of WashingtonResidency, Obstetrics and Gynecology, 2009 - 2012
- Wayne State University School of MedicineInternship, Transitional Year, 2008 - 2009
- University of Al-Mustansiriyah College of MedicineClass of 2004
Certifications & Licensure
- MI State Medical License 2008 - 2026
- OH State Medical License 2012 - 2024
- PA State Medical License 2020 - 2024
- American Board of Obstetrics and Gynecology Obstetrics & Gynecology
- American Board of Obstetrics and Gynecology Gynecologic Oncology
Publications & Presentations
PubMed
- An LC-MS/MS method for determination of the bromodomain inhibitor ZEN-3694 and its metabolite ZEN-3791 in human plasma.Ye Feng, Richard Piekarz, Jan H Beumer, Timothy W Synold, Haider Mahdi> ;Bioanalysis. 2024 Mar 18
- Computational pathology identifies immune-mediated collagen disruption to predict clinical outcomes in gynecologic malignancies.Aggarwal, A., Khalighi, S., Babu, D., Li, H., Azarianpour-Esfahani, S., Corredor, G., Fu, P., Mokhtari, M., Pathak, T., Thayer, E., Modesitt, S., Madabhushi, A., Mahdi...> ;Communications Medicine. 2024 Jan 3
- Carboplatin, paclitaxel, and pembrolizumab followed by pembrolizumab maintenance for primary treatment of incompletely resected epithelial ovarian cancer.Simpson, P., Zhang, L., Christian, Q., Uyar, D., Michener, C., Bishop, E., Hopp, E., Rader, J., Rose, P., Mahdi, H., Debernardo, R., Bradley, W.> ;Frontiers in Oncology. 2024 Jan 1
- Join now to see all
Lectures
- The role of different TGFβ signatures in predicting outcome in high grade serous ovarian carcinoma.2019 ASCO Annual Meeting - 6/1/2019
- The role of proinflammatory immune (IFN-gamma) gene signature in predicting prognosis and response to chemotherapy in uterine carcinoma.2019 ASCO Annual Meeting - 6/1/2019
Press Mentions
- ALX Oncology Doses First Patient in Trial of Evorpacept for Ovarian CancerMay 10th, 2023
- ALX Oncology Announces First Patient Dosed in Phase 2 Investigator-Sponsored Trial of Evorpacept in Patients with Ovarian CancerMay 9th, 2023
- Zenith Epigenetics Announces Dosing of First Cancer Patient with a Combination of ZEN-3694 + Bristol Myers Squibb's Immune Checkpoint Inhibitor OPDIVOFebruary 22nd, 2022
- Join now to see all
Hospital Affiliations
- Cleveland Clinic Fairview HospitalCleveland, Ohio
- Cleveland Clinic Medina HospitalMedina, Ohio
- Cleveland ClinicCleveland, Ohio
- UPMC Presbyterian ShadysidePittsburgh, Pennsylvania
- UPMC Magee-Womens HospitalPittsburgh, Pennsylvania
- UPMC Magee-Womens HospitalPittsburgh, Pennsylvania
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: